nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Stomach ache—Mitoxantrone—sarcoma	0.0297	0.0303	CcSEcCtD
Dextroamphetamine—Cardiomyopathy—Thiotepa—sarcoma	0.0286	0.0292	CcSEcCtD
Dextroamphetamine—Sudden death—Mitoxantrone—sarcoma	0.0247	0.0252	CcSEcCtD
Dextroamphetamine—Cardiomyopathy—Mitoxantrone—sarcoma	0.0247	0.0252	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—IL2—sarcoma	0.0199	1	CrCbGaD
Dextroamphetamine—Viral infection—Mitoxantrone—sarcoma	0.014	0.0143	CcSEcCtD
Dextroamphetamine—Cardiomyopathy—Epirubicin—sarcoma	0.0115	0.0118	CcSEcCtD
Dextroamphetamine—Cardiomyopathy—Doxorubicin—sarcoma	0.0107	0.0109	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.0095	0.00969	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Mitoxantrone—sarcoma	0.00838	0.00855	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00806	0.00822	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Vincristine—sarcoma	0.0075	0.00765	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Vincristine—sarcoma	0.00743	0.00758	CcSEcCtD
Dextroamphetamine—Weight decreased—Vincristine—sarcoma	0.00737	0.00752	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Mitoxantrone—sarcoma	0.0073	0.00745	CcSEcCtD
Dextroamphetamine—Depression—Vincristine—sarcoma	0.00724	0.00739	CcSEcCtD
Dextroamphetamine—Weight decreased—Mitoxantrone—sarcoma	0.00717	0.00732	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Vincristine—sarcoma	0.00716	0.0073	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Vincristine—sarcoma	0.00712	0.00726	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00697	0.00711	CcSEcCtD
Dextroamphetamine—Sweating—Vincristine—sarcoma	0.00696	0.0071	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Mitoxantrone—sarcoma	0.00693	0.00707	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Dactinomycin—sarcoma	0.0069	0.00704	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Mitoxantrone—sarcoma	0.00687	0.00701	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00687	0.00701	CcSEcCtD
Dextroamphetamine—Sweating—Mitoxantrone—sarcoma	0.00678	0.00692	CcSEcCtD
Dextroamphetamine—Viral infection—Epirubicin—sarcoma	0.00653	0.00666	CcSEcCtD
Dextroamphetamine—Tension—Thiotepa—sarcoma	0.00628	0.00641	CcSEcCtD
Dextroamphetamine—Dyskinesia—Epirubicin—sarcoma	0.00627	0.0064	CcSEcCtD
Dextroamphetamine—Nervousness—Thiotepa—sarcoma	0.00621	0.00634	CcSEcCtD
Dextroamphetamine—Viral infection—Doxorubicin—sarcoma	0.00604	0.00616	CcSEcCtD
Dextroamphetamine—Agitation—Thiotepa—sarcoma	0.00588	0.006	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00583	0.00595	CcSEcCtD
Dextroamphetamine—Dyskinesia—Doxorubicin—sarcoma	0.0058	0.00592	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Etoposide—sarcoma	0.0058	0.00592	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Etoposide—sarcoma	0.00577	0.00588	CcSEcCtD
Dextroamphetamine—Convulsion—Thiotepa—sarcoma	0.00554	0.00566	CcSEcCtD
Dextroamphetamine—Hypertension—Thiotepa—sarcoma	0.00552	0.00564	CcSEcCtD
Dextroamphetamine—Anxiety—Thiotepa—sarcoma	0.00543	0.00554	CcSEcCtD
Dextroamphetamine—Agitation—Vincristine—sarcoma	0.00521	0.00532	CcSEcCtD
Dextroamphetamine—Infection—Thiotepa—sarcoma	0.00519	0.00529	CcSEcCtD
Dextroamphetamine—Infection—Dactinomycin—sarcoma	0.00515	0.00525	CcSEcCtD
Dextroamphetamine—Tachycardia—Thiotepa—sarcoma	0.0051	0.0052	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Etoposide—sarcoma	0.00499	0.00509	CcSEcCtD
Dextroamphetamine—Anorexia—Thiotepa—sarcoma	0.00498	0.00508	CcSEcCtD
Dextroamphetamine—Anorexia—Dactinomycin—sarcoma	0.00494	0.00504	CcSEcCtD
Dextroamphetamine—Convulsion—Vincristine—sarcoma	0.00492	0.00502	CcSEcCtD
Dextroamphetamine—Hypertension—Vincristine—sarcoma	0.0049	0.005	CcSEcCtD
Dextroamphetamine—Convulsion—Mitoxantrone—sarcoma	0.00479	0.00488	CcSEcCtD
Dextroamphetamine—Hypertension—Mitoxantrone—sarcoma	0.00477	0.00487	CcSEcCtD
Dextroamphetamine—Chest pain—Mitoxantrone—sarcoma	0.0047	0.0048	CcSEcCtD
Dextroamphetamine—Anxiety—Mitoxantrone—sarcoma	0.00469	0.00478	CcSEcCtD
Dextroamphetamine—Somnolence—Thiotepa—sarcoma	0.00464	0.00474	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Vincristine—sarcoma	0.00463	0.00472	CcSEcCtD
Dextroamphetamine—Infection—Vincristine—sarcoma	0.0046	0.00469	CcSEcCtD
Dextroamphetamine—Dyspepsia—Thiotepa—sarcoma	0.0046	0.00469	CcSEcCtD
Dextroamphetamine—Decreased appetite—Thiotepa—sarcoma	0.00454	0.00463	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00451	0.0046	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00451	0.0046	CcSEcCtD
Dextroamphetamine—Decreased appetite—Dactinomycin—sarcoma	0.00451	0.0046	CcSEcCtD
Dextroamphetamine—Fatigue—Thiotepa—sarcoma	0.0045	0.00459	CcSEcCtD
Dextroamphetamine—Infection—Mitoxantrone—sarcoma	0.00448	0.00457	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Vincristine—sarcoma	0.00448	0.00457	CcSEcCtD
Dextroamphetamine—Fatigue—Dactinomycin—sarcoma	0.00447	0.00456	CcSEcCtD
Dextroamphetamine—Constipation—Thiotepa—sarcoma	0.00447	0.00456	CcSEcCtD
Dextroamphetamine—Anorexia—Vincristine—sarcoma	0.00441	0.0045	CcSEcCtD
Dextroamphetamine—Tachycardia—Mitoxantrone—sarcoma	0.0044	0.00449	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Epirubicin—sarcoma	0.00437	0.00445	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00436	0.00445	CcSEcCtD
Dextroamphetamine—Anorexia—Mitoxantrone—sarcoma	0.0043	0.00439	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Thiotepa—sarcoma	0.00427	0.00436	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00424	0.00432	CcSEcCtD
Dextroamphetamine—Affect lability—Epirubicin—sarcoma	0.00421	0.0043	CcSEcCtD
Dextroamphetamine—Insomnia—Vincristine—sarcoma	0.00419	0.00427	CcSEcCtD
Dextroamphetamine—Urticaria—Thiotepa—sarcoma	0.00415	0.00423	CcSEcCtD
Dextroamphetamine—Abdominal pain—Thiotepa—sarcoma	0.00413	0.00421	CcSEcCtD
Dextroamphetamine—Body temperature increased—Thiotepa—sarcoma	0.00413	0.00421	CcSEcCtD
Dextroamphetamine—Abdominal pain—Dactinomycin—sarcoma	0.0041	0.00418	CcSEcCtD
Dextroamphetamine—Body temperature increased—Dactinomycin—sarcoma	0.0041	0.00418	CcSEcCtD
Dextroamphetamine—Mood swings—Epirubicin—sarcoma	0.00405	0.00414	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Doxorubicin—sarcoma	0.00404	0.00412	CcSEcCtD
Dextroamphetamine—Decreased appetite—Vincristine—sarcoma	0.00403	0.00411	CcSEcCtD
Dextroamphetamine—Dyspnoea—Mitoxantrone—sarcoma	0.00402	0.0041	CcSEcCtD
Dextroamphetamine—Somnolence—Mitoxantrone—sarcoma	0.00401	0.00409	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Vincristine—sarcoma	0.004	0.00408	CcSEcCtD
Dextroamphetamine—Fatigue—Vincristine—sarcoma	0.00399	0.00407	CcSEcCtD
Dextroamphetamine—Convulsion—Etoposide—sarcoma	0.00398	0.00406	CcSEcCtD
Dextroamphetamine—Dyspepsia—Mitoxantrone—sarcoma	0.00397	0.00405	CcSEcCtD
Dextroamphetamine—Hypertension—Etoposide—sarcoma	0.00397	0.00405	CcSEcCtD
Dextroamphetamine—Constipation—Vincristine—sarcoma	0.00396	0.00404	CcSEcCtD
Dextroamphetamine—Decreased appetite—Mitoxantrone—sarcoma	0.00392	0.004	CcSEcCtD
Dextroamphetamine—Chest pain—Etoposide—sarcoma	0.00391	0.00399	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Epirubicin—sarcoma	0.00391	0.00399	CcSEcCtD
Dextroamphetamine—Affect lability—Doxorubicin—sarcoma	0.0039	0.00398	CcSEcCtD
Dextroamphetamine—Fatigue—Mitoxantrone—sarcoma	0.00389	0.00397	CcSEcCtD
Dextroamphetamine—Constipation—Mitoxantrone—sarcoma	0.00386	0.00393	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00385	0.00393	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Thiotepa—sarcoma	0.00385	0.00393	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Dactinomycin—sarcoma	0.00382	0.0039	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Vincristine—sarcoma	0.00379	0.00386	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Etoposide—sarcoma	0.00375	0.00383	CcSEcCtD
Dextroamphetamine—Mood swings—Doxorubicin—sarcoma	0.00375	0.00383	CcSEcCtD
Dextroamphetamine—Asthenia—Thiotepa—sarcoma	0.00375	0.00382	CcSEcCtD
Dextroamphetamine—Infection—Etoposide—sarcoma	0.00373	0.0038	CcSEcCtD
Dextroamphetamine—Asthenia—Dactinomycin—sarcoma	0.00372	0.00379	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00369	0.00376	CcSEcCtD
Dextroamphetamine—Tachycardia—Etoposide—sarcoma	0.00366	0.00374	CcSEcCtD
Dextroamphetamine—Abdominal pain—Vincristine—sarcoma	0.00366	0.00373	CcSEcCtD
Dextroamphetamine—Body temperature increased—Vincristine—sarcoma	0.00366	0.00373	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Etoposide—sarcoma	0.00363	0.0037	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Doxorubicin—sarcoma	0.00362	0.00369	CcSEcCtD
Dextroamphetamine—Urticaria—Mitoxantrone—sarcoma	0.00358	0.00366	CcSEcCtD
Dextroamphetamine—Anorexia—Etoposide—sarcoma	0.00358	0.00365	CcSEcCtD
Dextroamphetamine—Diarrhoea—Thiotepa—sarcoma	0.00357	0.00365	CcSEcCtD
Dextroamphetamine—Body temperature increased—Mitoxantrone—sarcoma	0.00357	0.00364	CcSEcCtD
Dextroamphetamine—Abdominal pain—Mitoxantrone—sarcoma	0.00357	0.00364	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00356	0.00364	CcSEcCtD
Dextroamphetamine—Diarrhoea—Dactinomycin—sarcoma	0.00355	0.00362	CcSEcCtD
Dextroamphetamine—Dizziness—Thiotepa—sarcoma	0.00345	0.00352	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Vincristine—sarcoma	0.00341	0.00348	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Epirubicin—sarcoma	0.00338	0.00344	CcSEcCtD
Dextroamphetamine—Weight decreased—Epirubicin—sarcoma	0.00335	0.00341	CcSEcCtD
Dextroamphetamine—Dyspnoea—Etoposide—sarcoma	0.00334	0.00341	CcSEcCtD
Dextroamphetamine—Somnolence—Etoposide—sarcoma	0.00333	0.0034	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Mitoxantrone—sarcoma	0.00332	0.00339	CcSEcCtD
Dextroamphetamine—Asthenia—Vincristine—sarcoma	0.00332	0.00339	CcSEcCtD
Dextroamphetamine—Vomiting—Thiotepa—sarcoma	0.00332	0.00339	CcSEcCtD
Dextroamphetamine—Vomiting—Dactinomycin—sarcoma	0.0033	0.00336	CcSEcCtD
Dextroamphetamine—Rash—Thiotepa—sarcoma	0.00329	0.00336	CcSEcCtD
Dextroamphetamine—Dermatitis—Thiotepa—sarcoma	0.00329	0.00336	CcSEcCtD
Dextroamphetamine—Headache—Thiotepa—sarcoma	0.00327	0.00334	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00327	0.00333	CcSEcCtD
Dextroamphetamine—Rash—Dactinomycin—sarcoma	0.00327	0.00333	CcSEcCtD
Dextroamphetamine—Decreased appetite—Etoposide—sarcoma	0.00326	0.00333	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Etoposide—sarcoma	0.00324	0.0033	CcSEcCtD
Dextroamphetamine—Asthenia—Mitoxantrone—sarcoma	0.00324	0.0033	CcSEcCtD
Dextroamphetamine—Fatigue—Etoposide—sarcoma	0.00323	0.0033	CcSEcCtD
Dextroamphetamine—Constipation—Etoposide—sarcoma	0.00321	0.00327	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Epirubicin—sarcoma	0.0032	0.00327	CcSEcCtD
Dextroamphetamine—Diarrhoea—Vincristine—sarcoma	0.00317	0.00323	CcSEcCtD
Dextroamphetamine—Sweating—Epirubicin—sarcoma	0.00316	0.00322	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Doxorubicin—sarcoma	0.00312	0.00319	CcSEcCtD
Dextroamphetamine—Nausea—Thiotepa—sarcoma	0.0031	0.00316	CcSEcCtD
Dextroamphetamine—Weight decreased—Doxorubicin—sarcoma	0.0031	0.00316	CcSEcCtD
Dextroamphetamine—Diarrhoea—Mitoxantrone—sarcoma	0.00309	0.00315	CcSEcCtD
Dextroamphetamine—Nausea—Dactinomycin—sarcoma	0.00308	0.00314	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Etoposide—sarcoma	0.00307	0.00313	CcSEcCtD
Dextroamphetamine—Dizziness—Vincristine—sarcoma	0.00306	0.00312	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00302	0.00309	CcSEcCtD
Dextroamphetamine—Urticaria—Etoposide—sarcoma	0.00298	0.00304	CcSEcCtD
Dextroamphetamine—Body temperature increased—Etoposide—sarcoma	0.00297	0.00303	CcSEcCtD
Dextroamphetamine—Abdominal pain—Etoposide—sarcoma	0.00297	0.00303	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Doxorubicin—sarcoma	0.00297	0.00303	CcSEcCtD
Dextroamphetamine—Vomiting—Vincristine—sarcoma	0.00294	0.003	CcSEcCtD
Dextroamphetamine—Sweating—Doxorubicin—sarcoma	0.00292	0.00298	CcSEcCtD
Dextroamphetamine—Rash—Vincristine—sarcoma	0.00292	0.00298	CcSEcCtD
Dextroamphetamine—Dermatitis—Vincristine—sarcoma	0.00292	0.00298	CcSEcCtD
Dextroamphetamine—Headache—Vincristine—sarcoma	0.0029	0.00296	CcSEcCtD
Dextroamphetamine—Vomiting—Mitoxantrone—sarcoma	0.00287	0.00293	CcSEcCtD
Dextroamphetamine—Rash—Mitoxantrone—sarcoma	0.00284	0.0029	CcSEcCtD
Dextroamphetamine—Dermatitis—Mitoxantrone—sarcoma	0.00284	0.0029	CcSEcCtD
Dextroamphetamine—Headache—Mitoxantrone—sarcoma	0.00283	0.00288	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Epirubicin—sarcoma	0.0028	0.00286	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Etoposide—sarcoma	0.00276	0.00282	CcSEcCtD
Dextroamphetamine—Nausea—Vincristine—sarcoma	0.00275	0.00281	CcSEcCtD
Dextroamphetamine—Asthenia—Etoposide—sarcoma	0.00269	0.00275	CcSEcCtD
Dextroamphetamine—Nausea—Mitoxantrone—sarcoma	0.00268	0.00273	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Doxorubicin—sarcoma	0.00259	0.00264	CcSEcCtD
Dextroamphetamine—Diarrhoea—Etoposide—sarcoma	0.00257	0.00262	CcSEcCtD
Dextroamphetamine—Tension—Epirubicin—sarcoma	0.00253	0.00258	CcSEcCtD
Dextroamphetamine—Nervousness—Epirubicin—sarcoma	0.0025	0.00255	CcSEcCtD
Dextroamphetamine—Dizziness—Etoposide—sarcoma	0.00248	0.00253	CcSEcCtD
Dextroamphetamine—Vomiting—Etoposide—sarcoma	0.00239	0.00243	CcSEcCtD
Dextroamphetamine—Agitation—Epirubicin—sarcoma	0.00237	0.00242	CcSEcCtD
Dextroamphetamine—Rash—Etoposide—sarcoma	0.00237	0.00241	CcSEcCtD
Dextroamphetamine—Dermatitis—Etoposide—sarcoma	0.00236	0.00241	CcSEcCtD
Dextroamphetamine—Headache—Etoposide—sarcoma	0.00235	0.0024	CcSEcCtD
Dextroamphetamine—Tension—Doxorubicin—sarcoma	0.00234	0.00239	CcSEcCtD
Dextroamphetamine—Nervousness—Doxorubicin—sarcoma	0.00232	0.00236	CcSEcCtD
Dextroamphetamine—Palpitations—Epirubicin—sarcoma	0.00228	0.00232	CcSEcCtD
Dextroamphetamine—Convulsion—Epirubicin—sarcoma	0.00223	0.00228	CcSEcCtD
Dextroamphetamine—Nausea—Etoposide—sarcoma	0.00223	0.00227	CcSEcCtD
Dextroamphetamine—Hypertension—Epirubicin—sarcoma	0.00222	0.00227	CcSEcCtD
Dextroamphetamine—Chest pain—Epirubicin—sarcoma	0.00219	0.00224	CcSEcCtD
Dextroamphetamine—Agitation—Doxorubicin—sarcoma	0.00219	0.00224	CcSEcCtD
Dextroamphetamine—Anxiety—Epirubicin—sarcoma	0.00219	0.00223	CcSEcCtD
Dextroamphetamine—Dry mouth—Epirubicin—sarcoma	0.00215	0.00219	CcSEcCtD
Dextroamphetamine—Palpitations—Doxorubicin—sarcoma	0.00211	0.00215	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Epirubicin—sarcoma	0.0021	0.00215	CcSEcCtD
Dextroamphetamine—Infection—Epirubicin—sarcoma	0.00209	0.00213	CcSEcCtD
Dextroamphetamine—Convulsion—Doxorubicin—sarcoma	0.00207	0.00211	CcSEcCtD
Dextroamphetamine—Hypertension—Doxorubicin—sarcoma	0.00206	0.0021	CcSEcCtD
Dextroamphetamine—Tachycardia—Epirubicin—sarcoma	0.00205	0.00209	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Epirubicin—sarcoma	0.00203	0.00207	CcSEcCtD
Dextroamphetamine—Chest pain—Doxorubicin—sarcoma	0.00203	0.00207	CcSEcCtD
Dextroamphetamine—Anxiety—Doxorubicin—sarcoma	0.00202	0.00206	CcSEcCtD
Dextroamphetamine—Anorexia—Epirubicin—sarcoma	0.002	0.00205	CcSEcCtD
Dextroamphetamine—Dry mouth—Doxorubicin—sarcoma	0.00198	0.00203	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Doxorubicin—sarcoma	0.00195	0.00199	CcSEcCtD
Dextroamphetamine—Infection—Doxorubicin—sarcoma	0.00193	0.00197	CcSEcCtD
Dextroamphetamine—Insomnia—Epirubicin—sarcoma	0.0019	0.00194	CcSEcCtD
Dextroamphetamine—Tachycardia—Doxorubicin—sarcoma	0.0019	0.00194	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Doxorubicin—sarcoma	0.00188	0.00192	CcSEcCtD
Dextroamphetamine—Dyspnoea—Epirubicin—sarcoma	0.00187	0.00191	CcSEcCtD
Dextroamphetamine—Somnolence—Epirubicin—sarcoma	0.00187	0.00191	CcSEcCtD
Dextroamphetamine—Anorexia—Doxorubicin—sarcoma	0.00185	0.00189	CcSEcCtD
Dextroamphetamine—Dyspepsia—Epirubicin—sarcoma	0.00185	0.00189	CcSEcCtD
Dextroamphetamine—Decreased appetite—Epirubicin—sarcoma	0.00183	0.00186	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Epirubicin—sarcoma	0.00182	0.00185	CcSEcCtD
Dextroamphetamine—Fatigue—Epirubicin—sarcoma	0.00181	0.00185	CcSEcCtD
Dextroamphetamine—Constipation—Epirubicin—sarcoma	0.0018	0.00183	CcSEcCtD
Dextroamphetamine—Insomnia—Doxorubicin—sarcoma	0.00176	0.0018	CcSEcCtD
Dextroamphetamine—Dyspnoea—Doxorubicin—sarcoma	0.00173	0.00177	CcSEcCtD
Dextroamphetamine—Somnolence—Doxorubicin—sarcoma	0.00173	0.00176	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Epirubicin—sarcoma	0.00172	0.00175	CcSEcCtD
Dextroamphetamine—Dyspepsia—Doxorubicin—sarcoma	0.00171	0.00175	CcSEcCtD
Dextroamphetamine—Decreased appetite—Doxorubicin—sarcoma	0.00169	0.00173	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00168	0.00171	CcSEcCtD
Dextroamphetamine—Fatigue—Doxorubicin—sarcoma	0.00168	0.00171	CcSEcCtD
Dextroamphetamine—Urticaria—Epirubicin—sarcoma	0.00167	0.0017	CcSEcCtD
Dextroamphetamine—Constipation—Doxorubicin—sarcoma	0.00166	0.0017	CcSEcCtD
Dextroamphetamine—Abdominal pain—Epirubicin—sarcoma	0.00166	0.0017	CcSEcCtD
Dextroamphetamine—Body temperature increased—Epirubicin—sarcoma	0.00166	0.0017	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Doxorubicin—sarcoma	0.00159	0.00162	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Epirubicin—sarcoma	0.00155	0.00158	CcSEcCtD
Dextroamphetamine—Urticaria—Doxorubicin—sarcoma	0.00155	0.00158	CcSEcCtD
Dextroamphetamine—Body temperature increased—Doxorubicin—sarcoma	0.00154	0.00157	CcSEcCtD
Dextroamphetamine—Abdominal pain—Doxorubicin—sarcoma	0.00154	0.00157	CcSEcCtD
Dextroamphetamine—Asthenia—Epirubicin—sarcoma	0.00151	0.00154	CcSEcCtD
Dextroamphetamine—Diarrhoea—Epirubicin—sarcoma	0.00144	0.00147	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Doxorubicin—sarcoma	0.00143	0.00146	CcSEcCtD
Dextroamphetamine—Asthenia—Doxorubicin—sarcoma	0.0014	0.00142	CcSEcCtD
Dextroamphetamine—Dizziness—Epirubicin—sarcoma	0.00139	0.00142	CcSEcCtD
Dextroamphetamine—Vomiting—Epirubicin—sarcoma	0.00134	0.00136	CcSEcCtD
Dextroamphetamine—Diarrhoea—Doxorubicin—sarcoma	0.00133	0.00136	CcSEcCtD
Dextroamphetamine—Rash—Epirubicin—sarcoma	0.00133	0.00135	CcSEcCtD
Dextroamphetamine—Dermatitis—Epirubicin—sarcoma	0.00132	0.00135	CcSEcCtD
Dextroamphetamine—Headache—Epirubicin—sarcoma	0.00132	0.00134	CcSEcCtD
Dextroamphetamine—Dizziness—Doxorubicin—sarcoma	0.00129	0.00131	CcSEcCtD
Dextroamphetamine—Nausea—Epirubicin—sarcoma	0.00125	0.00127	CcSEcCtD
Dextroamphetamine—Vomiting—Doxorubicin—sarcoma	0.00124	0.00126	CcSEcCtD
Dextroamphetamine—Rash—Doxorubicin—sarcoma	0.00123	0.00125	CcSEcCtD
Dextroamphetamine—Dermatitis—Doxorubicin—sarcoma	0.00123	0.00125	CcSEcCtD
Dextroamphetamine—Headache—Doxorubicin—sarcoma	0.00122	0.00124	CcSEcCtD
Dextroamphetamine—Nausea—Doxorubicin—sarcoma	0.00116	0.00118	CcSEcCtD
